Table 1.
Model | Renal phenotype | Cardiovascular phenotype | Other phenotype | References |
---|---|---|---|---|
Global overexpression of human PRR in the rat | Glomerulosclerosis Proteinuria | Elevated blood pressure | Unknown | [54] |
Targeted overexpression of human PRR in rat vasculature | Unknown | Elevated blood pressure and heart rate | Unknown | [77] |
SHR rats treated with PRR blocker | Attenuation of renal fibrosis | Attenuation of cardiac fibrosis | Unknown | [78] |
Mice with targeted deletion of Prr in cardiomyocytes | Unknown | Cardiac tissue Fibrosis Cardiomyocyt opoptosis | Unknown | [71] |
Xenopus embryos treated with anti-PRR morpholino | Unknown | Unknown | Short body axis Impaired CE Small head Short tail Defects in eye pigmentation |
[79] [56] |
Genetic polymorphism of PRR in humans | Unknown | Hypertension in men LVH in women | Unknown | [80] |
Unknown | [81] | |||
Hypomorphic PRR mutations in humans | Unknown | Unknown | X-linked mental retardation Epilepsy | [76] |
SHR: spontaneously hypertensive rats, CE: convergent extension, LVH: left ventricular hypertrophy, PRR: human PRR gene, PRR: human PRR protein, Prr: mouse PRR gene.